Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 145 articles: HTML format

Single Articles

July 2023
1. ARAKI T, Kondo T, Imaizumi T, Sumita Y, et al
   Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support.
   Am Heart J. 2023;261:109-123.
   PubMed     Abstract available
   
   
   June 2023
2. WANG X, Guo R, Guo Y, Guo Q, et al
   Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
   Am Heart J. 2023;260:9-17.
   PubMed     Abstract available
   
   
   May 2023
3. ATALLAH J, Chiha T, Chen C, Siller-Matula JM, et al
   Clinical Outcomes Associated with Type II Myocardial Infarction Caused by Bleeding.
   Am Heart J. 2023 May 16:S0002-8703(23)00119-9. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
4. SHAH NP, Peterson ED, Page C, Blanco R, et al
   Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.
   Am Heart J. 2023 May 15:S0002-8703(23)00120-5. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
5. HANER JD, Rohla M, Losdat S, Iglesias JF, et al
   Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials.
   Am Heart J. 2023 May 14:S0002-8703(23)00115-1. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
6. ANANTH CV, Rutherford C, Rosenfeld EB, Brandt JS, et al
   Epidemiologic Trends and Risk Factors Associated with the Decline in Mortality from Coronary Heart Disease in the United States, 1990-2019.
   Am Heart J. 2023 May 11:S0002-8703(23)00117-5. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
7. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
   Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
   Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   April 2023
8. LI N, Chen R, Li J, Zhao X, et al
   Prognostic significance of serial NT-proBNP levels in patients with acute myocardial infarction: A prospective study.
   Am Heart J. 2023 Apr 26:S0002-8703(23)00110-2. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
9. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
   Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
   Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
   PubMed     Abstract available
   
   
   
10. CHIUSOLO S, Bork CS, Gentile F, Lundbye-Christensen S, et al
    Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction.
    Am Heart J. 2023 Apr 20:S0002-8703(23)00089-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
11. BROWN JY, Drakeley S, Duncan M, Knapp WP, et al
    Moderate Intensity Exercise in Pregnant Patients with Cardiovascular Disease: A Pilot Study.
    Am Heart J. 2023 Apr 16:S0002-8703(23)00090-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
12. HUANG D, Gong Y, Fan Y, Zheng B, et al
    Coronary Angiography-Derived Index for Assessing Microcirculatory Resistance in Patients with Non-Obstructed Vessels: The FLASH IMR Study.
    Am Heart J. 2023 Apr 11:S0002-8703(23)00088-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
13. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
14. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    PubMed     Abstract available
    
    
    
15. AUER J, Lamm G
    Blood pressure control in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:186-189.
    PubMed    
    
    
    
16. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
    Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Am Heart J. 2023;258:49-59.
    PubMed     Abstract available
    
    
    March 2023
17. CHA JJ, Hong SJ, Kim JH, Lim S, et al
    Effect of rosuvastatin 20mg versus rosuvastatin 5mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00064-9. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
18. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
19. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    A Randomized Controlled Trial of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients with Elevated Risk for Cardiovascular Disease: Rationale and Design of the BE ACTIVE Study.
    Am Heart J. 2023 Mar 2:S0002-8703(23)00048-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
20. DEFILIPPIS AP, Lidani KCF, Nam Y, Trainor PJ, et al
    Risk Factor Associations with Individual Myocardial Infarction Subtypes and Acute Non-Ischemic Myocardial Injury in the Multi-Ethnic Study of Atherosclerosis (MESA): Design and Rationale.
    Am Heart J. 2023 Mar 1:S0002-8703(23)00047-9. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    February 2023
21. CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
    External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
    Am Heart J. 2023 Feb 23:S0002-8703(23)00046-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
22. DAVIDSON SJ, Roncalli J, Surder D, Corti R, et al
    Microvascular Obstruction Identifies a Subgroup of Patients Who Benefit from Stem Cell Therapy Following ST-Elevation Myocardial Infarction.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00037-6. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
23. SCOCCIA A, Byrne RA, Banning AP, Landmesser U, et al
    Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization. Rationale and study design of the prospective randomized FAST III Trial.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00036-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
24. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
25. KAUL U, Arambam P, Sinha SK, Abhaichand R, et al
    Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
    Am Heart J. 2023;256:128-138.
    PubMed     Abstract available
    
    
    January 2023
26. SILVAIN J, Cayla G, Ferrari E, Range G, et al
    betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
    Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
27. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
28. BHATT AS, Daniels LB, de Lemos J, Goodrich E, et al
    Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Am Heart J. 2023 Jan 17:S0002-8703(22)00334-9. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
29. CHOUAIRI F, Pinsker B, Fudim M, Miller PE, et al
    Trends in Outcomes and Resource Utilization for Acute Myocardial Infarction Admissions During the COVID-19 Pandemic.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00012-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
30. BRANCH KRH, Probstfield JL, Bosch J, Bhatt DL, et al
    Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00015-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
31. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
32. SPAULDING C, Krackhardt F, Bogaerts K, Urban P, et al
    Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00010-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
33. MOLLER JE, Gerke O
    Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
    Am Heart J. 2023;255:90-93.
    PubMed     Abstract available
    
    
    
34. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Nestelberger T, et al
    Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm.
    Am Heart J. 2023;255:58-70.
    PubMed     Abstract available
    
    
    December 2022
35. DELEWI R, Vogel RF, Wilschut JM, Lemmert ME, et al
    Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00335-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
36. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
37. EKMEJIAN A, Allahwala U, Ward M, Bhindi R, et al
    Impact of coronary disease patterns, anatomical factors, micro-vascular disease and non-coronary cardiac factors on invasive coronary physiology.
    Am Heart J. 2022 Dec 9:S0002-8703(22)00327-1. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
38. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
39. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
40. ANTHOPOLOS R, Maron DJ, Bangalore S, Reynolds HR, et al
    ISCHEMIA-EXTEND studies: Rationale and design.
    Am Heart J. 2022;254:228-233.
    PubMed     Abstract available
    
    
    
41. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    PubMed     Abstract available
    
    
    November 2022
42. RAMUNDDAL T, Holck EN, Karim S, Eftekhari A, et al
    International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions with Myocardial Ischemia - ISCHEMIA-CTO Trial - Rationale and Design.
    Am Heart J. 2022 Nov 21:S0002-8703(22)00298-8. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
43. CARSON JL, Brooks MM, Chaitman BR, Alexander JH, et al
    Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial.
    Am Heart J. 2022 Nov 20:S0002-8703(22)00297-6. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
44. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
45. SNAVELY AC, Paradee BE, Ashburn NP, Allen BR, et al
    Derivation and validation of a high sensitivity troponin-T HEART pathway.
    Am Heart J. 2022;256:148-157.
    PubMed     Abstract available
    
    
    
46. SPIRITO A, Sticchi A, Praz F, Grani C, et al
    Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00291.
    PubMed     Abstract available
    
    
    
47. DE CARVALHO FPC, Hueb W, Lima EG, Rezende PC, et al
    Cardiovascular Events in Patients with Coronary Artery Disease with and Without Myocardial Ischemia: Long-Term Follow-Up.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00293.
    PubMed     Abstract available
    
    
    
48. KOIVUNEN M, Tynkkynen J, Oksala N, Eskola M, et al
    Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction.
    Am Heart J. 2022 Nov 13. pii: S0002-8703(22)00290.
    PubMed     Abstract available
    
    
    
49. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00289.
    PubMed     Abstract available
    
    
    
50. CORNELISSEN A, Guo L, Neally SJ, Kleinberg L, et al
    Relationships Between Neighborhood Disadvantage and Cardiovascular Findings at Autopsy in Subjects with Sudden Death.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00284.
    PubMed     Abstract available
    
    
    
51. NISHIZAKI Y, Miyauchi K, Iwata H, Inoue T, et al
    Study Protocol and Baseline Characteristics of Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, The Combination of a Randomized Control Trial and an Observational Bioma
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00282.
    PubMed     Abstract available
    
    
    
52. NOUHRAVESH N, Strange JE, Tonnesen J, Holt A, et al
    Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study.
    Am Heart J. 2022 Nov 9. pii: S0002-8703(22)00281.
    PubMed     Abstract available
    
    
    
53. YEN TH, Yen JS
    Chelation trial in patients with cardiovascular disease.
    Am Heart J. 2022 Nov 3. pii: S0002-8703(22)00279.
    PubMed    
    
    
    
54. GARCIA H, Springer B, Vengrenyuk A, Krishnamoorthy P, et al
    Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project.
    Am Heart J. 2022;253:30-38.
    PubMed     Abstract available
    
    
    October 2022
55. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
    Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial.
    Am Heart J. 2022 Oct 21. pii: S0002-8703(22)00198.
    PubMed     Abstract available
    
    
    
56. GASPARDONE C, Romagnolo D, Fasolino A, Falasconi G, et al
    A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Oct 19. pii: S0002-8703(22)00272.
    PubMed     Abstract available
    
    
    
57. WOLNY R, Niedziela J, Desperak P, Kwiecinski J, et al
    Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry.
    Am Heart J. 2022 Oct 12. pii: S0002-8703(22)00200.
    PubMed     Abstract available
    
    
    
58. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    PubMed     Abstract available
    
    
    
59. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    PubMed     Abstract available
    
    
    
60. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    PubMed     Abstract available
    
    
    
61. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    PubMed     Abstract available
    
    
    
62. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    PubMed     Abstract available
    
    
    
63. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    The trial to assess chelation therapy 2 (TACT2): Rationale and design.
    Am Heart J. 2022;252:1-11.
    PubMed     Abstract available
    
    
    September 2022
64. DESAI RJ, Glynn RJ, Everett BM, Schneeweiss S, et al
    Comparative effectiveness of empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
    Am Heart J. 2022 Sep 20. pii: S0002-8703(22)00193.
    PubMed     Abstract available
    
    
    
65. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    PubMed     Abstract available
    
    
    
66. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
    Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
    Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
    PubMed     Abstract available
    
    
    August 2022
67. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    PubMed     Abstract available
    
    
    
68. KRANENDONK J, Willems LH, Vijver-Coppen RV, Coenen M, et al
    CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD).
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00163.
    PubMed     Abstract available
    
    
    
69. UKAH UV, Li X, Wei SQ, Healy-Profitos J, et al
    Black-White disparity in severe cardiovascular maternal morbidity: a systematic review and meta-analysis.
    Am Heart J. 2022 Aug 6. pii: S0002-8703(22)00162.
    PubMed     Abstract available
    
    
    
70. SHAVADIA JS, Wilson J, Edmonston D, Platt A, et al
    Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44].
    Am Heart J. 2022 Aug 4. pii: S0002-8703(22)00142.
    PubMed    
    
    
    July 2022
71. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    PubMed     Abstract available
    
    
    
72. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
    Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
    Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
    PubMed     Abstract available
    
    
    
73. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    PubMed     Abstract available
    
    
    
74. AKINYELURE OP, Colantonio LD, Chaudhary NS, Jaeger BC, et al
    Inflammation biomarkers and incident coronary heart disease: The Reasons for Geographic and Racial Differences in Stroke Study.
    Am Heart J. 2022 Jul 7. pii: S0002-8703(22)00144.
    PubMed     Abstract available
    
    
    June 2022
75. MOHEBI R, McCarthy CP, Gaggin HK, Kimmenade RRJV, et al
    Inflammatory Biomarkers and Risk of Cardiovascular Events in Patients Undergoing Coronary Angiography.
    Am Heart J. 2022 Jun 23. pii: S0002-8703(22)00128.
    PubMed     Abstract available
    
    
    
76. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    PubMed     Abstract available
    
    
    
77. VOGEL RF, Delewi R, Wilschut JM, Lemmert ME, et al
    Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial.
    Am Heart J. 2022 Jun 4. pii: S0002-8703(22)00116.
    PubMed     Abstract available
    
    
    
78. REIFFEL JA
    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    PubMed    
    
    
    
79. ISLEK D, Alonso A, Rosamond W, Kucharska-Newton A, et al
    Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC Community Surveillance Study.
    Am Heart J. 2022 Jun 1. pii: S0002-8703(22)00114.
    PubMed     Abstract available
    
    
    May 2022
80. MAZHAR F, Hjemdahl P, Clase CM, Johnell K, et al
    Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00115.
    PubMed     Abstract available
    
    
    
81. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    PubMed     Abstract available
    
    
    
82. KHAN MINHAS AM, Ijaz SH, Javed N, Sheikh AB, et al
    National Trends and Disparities in Statin Use for Ischemic Heart Disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00109.
    PubMed     Abstract available
    
    
    
83. OMEROVIC E, Erlinge D, Koul S, Frobert O, et al
    Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00112.
    PubMed     Abstract available
    
    
    
84. BLUMENTHAL JA, Smith PJ, Jiang W, Hinderliter A, et al
    Longer Term Benefits of Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: Six Month Follow-up of the UNWIND Randomized Clinical Trial.
    Am Heart J. 2022 May 21. pii: S0002-8703(22)00106.
    PubMed     Abstract available
    
    
    
85. NEWMAN JD, Douglas PS, Zhbannikov I, Ferencik M, et al
    Associations of a Polygenic Risk Score with Coronary Artery Disease Phenotypes in The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial.
    Am Heart J. 2022 May 20. pii: S0002-8703(22)00104.
    PubMed     Abstract available
    
    
    
86. HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
    Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.
    Am Heart J. 2022 May 17. pii: S0002-8703(22)00095.
    PubMed     Abstract available
    
    
    
87. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
    Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
    PubMed     Abstract available
    
    
    
88. O'DONOGHUE ML, Lopez JAG, Knusel B, Gencer B, et al
    Study Design and Rationale for the OCEAN(a)-DOSE (Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction-DOSE Finding Study) Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00086.
    PubMed     Abstract available
    
    
    
89. FORREST IS, Chan L, Chaudhary K, Saha A, et al
    Genome-First Recall of Healthy Individuals by Polygenic Risk Score Reveals Differences in Coronary Artery Calcium.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00081.
    PubMed     Abstract available
    
    
    
90. DENOBLE AE, Goldstein SA, Wein MLE, Grotegut CA, et al
    Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00084.
    PubMed     Abstract available
    
    
    
91. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    PubMed     Abstract available
    
    
    April 2022
92. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    PubMed     Abstract available
    
    
    
93. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    PubMed     Abstract available
    
    
    March 2022
94. UDELL JA, Lu D, Bagai A, Dodson JA, et al
    Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
    Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
    PubMed     Abstract available
    
    
    
95. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    PubMed     Abstract available
    
    
    
96. ERQOU S, Papaila A, Halladay C, Ge A, et al
    Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
    PubMed     Abstract available
    
    
    
97. GENEREUX P, Chernin G, Assali AR, Peruga JZ, et al
    Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.
    Am Heart J. 2022 Mar 16. pii: S0002-8703(22)00052.
    PubMed     Abstract available
    
    
    
98. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
    Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
    Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
    PubMed     Abstract available
    
    
    
99. TIAN X, Zuo Y, Chen S, Meng X, et al
    Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults.
    Am Heart J. 2022 Mar 3. pii: S0002-8703(22)00047.
    PubMed     Abstract available
    
    
    
100. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
     The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
     Am Heart J. 2022;245:136-148.
     PubMed     Abstract available
     
     
     February 2022
101. VERMA KP, Marwick T, Duarte C, Meikle P, et al
     Use of Coronary Computed Tomography or Polygenic Risk Scores to Prompt Action to Reduce Coronary Artery Disease Risk: The CAPAR-CAD Trial.
     Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00040.
     PubMed     Abstract available
     
     
     
102. COUCH SC, Helsley RN, Siegel FU, Saelens BE, et al
     Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.
     Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00044.
     PubMed     Abstract available
     
     
     
103. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
     Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
     Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
     PubMed     Abstract available
     
     
     
104. CHO MS, Kang DY, Oh YS, Lee CH, et al
     Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
     Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
     PubMed     Abstract available
     
     
     
105. SIDHU MS, Alexander KP, Huang Z, O'Brien SM, et al
     Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
     Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00026.
     PubMed     Abstract available
     
     
     
106. HASSAN R, Riehl-Tonn V, Dumanski SM, Lyons KJ, et al
     Female Sex-Specific Cardiovascular Risk Factors and Heart Failure Practice Guidelines.
     Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00008.
     PubMed     Abstract available
     
     
     
107. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
     Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
     Am Heart J. 2022;244:125-134.
     PubMed     Abstract available
     
     
     January 2022
108. JAIN B, Bajaj SS, Paguio JA, Yao JS, et al
     Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease.
     Am Heart J. 2022 Jan 27. pii: S0002-8703(22)00011.
     PubMed     Abstract available
     
     
     
109. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
     Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
     Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
     PubMed     Abstract available
     
     
     
110. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
     Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial.
     Am Heart J. 2022 Jan 20. pii: S0002-8703(22)00009.
     PubMed     Abstract available
     
     
     
111. TIES D, van Dorp P, Pundziute G, van der Aalst CM, et al
     Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
     Am Heart J. 2022 Jan 13. pii: S0002-8703(22)00005.
     PubMed     Abstract available
     
     
     
112. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
     One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
     Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
     PubMed     Abstract available
     
     
     
113. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
     Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
     Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
     PubMed     Abstract available
     
     
     
114. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
     Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
     Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
     PubMed     Abstract available
     
     
     
115. HARA H, Serruys PW, O'Leary N, Gao C, et al
     Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
     Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
     PubMed     Abstract available
     
     
     
116. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
     Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
     Am Heart J. 2022;243:187-200.
     PubMed     Abstract available
     
     
     December 2021
117. RIFAI MA, Mahtta D, Ramsey DJ, Lee MT, et al
     nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
     Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00480.
     PubMed     Abstract available
     
     
     
118. HSU B, Carcel C, Wang X, Peters SAE, et al
     Erratum to "Sex differences in emergency medical services management of patients with myocardial infarction: Analysis of routinely collected data for over 110,000 patients" [Am Heart J (2021) 87-91].
     Am Heart J. 2021 Dec 24. pii: S0002-8703(21)00451.
     PubMed    
     
     
     
119. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
     Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
     Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
     PubMed     Abstract available
     
     
     
120. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
     Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
     Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
     PubMed     Abstract available
     
     
     
121. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
     Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
     Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
     PubMed     Abstract available
     
     
     
122. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
     The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
     Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
     PubMed     Abstract available
     
     
     
123. SIEGMUND AS, Pieper PG, Bilardo CM, Gordijn SJ, et al
     Cardiovascular Determinants of Impaired Placental Function in Women with Cardiac Dysfunction.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00473.
     PubMed     Abstract available
     
     
     
124. ACQUAH I, Hagan K, Valero-Elizondo J, Javed Z, et al
     Delayed Medical Care due to Transportation Barriers Among Adults with Atherosclerotic Cardiovascular Disease.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00472.
     PubMed     Abstract available
     
     
     
125. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
     Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
     PubMed     Abstract available
     
     
     
126. BHASIN S, Lincoff AM, Basaria S, Bauer DC, et al
     Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.
     Am Heart J. 2021 Dec 3. pii: S0002-8703(21)00467.
     PubMed     Abstract available
     
     
     
127. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
     Association of STEMI regionalization of care with de facto NSTEMI regionalization.
     Am Heart J. 2021;242:1-5.
     PubMed     Abstract available
     
     
     November 2021
128. AKHABUE E, Wong M, Mehta R, Isakova T, et al
     Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
     Am Heart J. 2021 Nov 30. pii: S0002-8703(21)00460.
     PubMed     Abstract available
     
     
     
129. HUANG D, Wu H, Zhou J, Zhong X, et al
     Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
     Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
     PubMed     Abstract available
     
     
     
130. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
     Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
     Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
     PubMed     Abstract available
     
     
     
131. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
     Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
     Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
     PubMed     Abstract available
     
     
     
132. MERT GO, Babayigit E, Gorenek B
     The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
     Am Heart J. 2021;241:121.
     PubMed    
     
     
     
133. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
     The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
     Am Heart J. 2021;241:92-100.
     PubMed     Abstract available
     
     
     
134. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
     Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
     Am Heart J. 2021;241:101-107.
     PubMed     Abstract available
     
     
     
135. POVSIC TJ, Henry TD, Ohman EM, Pepine CJ, et al
     Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
     Am Heart J. 2021;241:38-49.
     PubMed     Abstract available
     
     
     October 2021
136. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
     Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
     Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
     PubMed     Abstract available
     
     
     
137. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
     Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
     Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
     PubMed     Abstract available
     
     
     
138. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
     Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
     Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
     PubMed     Abstract available
     
     
     
139. CHACIN-SUAREZ A, Grace SL, Anchique-Santos C, Supervia M, et al
     Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison.
     Am Heart J. 2021;240:16-27.
     PubMed     Abstract available
     
     
     September 2021
140. PANKAYATSELVAN V, Mukamal KJ
     Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
     Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
     PubMed     Abstract available
     
     
     
141. CAINZOS-ACHIRICA M, Anugula D, Mszar R, Grandhi G, et al
     Rationale and Pathways Forward in the Implementation of Coronary Artery Calcium-Based Enrichment of Randomized Trials.
     Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00235.
     PubMed     Abstract available
     
     
     
142. SALAH HM, Khan Minhas AM, Khan MS, Khan SU, et al
     Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018.
     Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00238.
     PubMed     Abstract available
     
     
     
143. YIN Y, Fang C, Jiang S, Wang J, et al
     In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.
     Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00236.
     PubMed     Abstract available
     
     
     July 2021
144. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
     Admission Rates During a Second COVID-19 Lockdown.
     Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
     PubMed     Abstract available
     
     
     June 2021
145. ABE M, Ozaki Y, Takahashi H, Ishii M, et al
     Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
     Am Heart J. 2021 Jun 23. pii: S0002-8703(21)00165.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: